MedPath

Effect of tDCS on Upper Extremity After Strokes

Not Applicable
Conditions
Stroke
Registration Number
NCT02987361
Lead Sponsor
Chonbuk National University Hospital
Brief Summary

The investigators hypothesize that transcranial direct current stimulation (tDCS) can improve upper limb motor recovery in the sub-acute phase of stroke patients.

This is a randomized, controlled, double blind, cross-over, multicentre, clinical trial.

Detailed Description

The investigators hypothesize that transcranial direct current stimulation (tDCS) can improve upper limb motor recovery in the sub-acute phase of stroke patients.

This is a randomized, controlled, double blind, cross-over, multicentre, clinical trial.

Informed consent was obtained from all participants and procedures were conducted according to the Declaration of Helsinki. The protocol was approved by the Chonbuk National Uni. Hospital IRB, KOREA.

Seventy-two stroke patients in the sub-acute phase will be recruited in three centers of neurorehabilitation in republic of Korea.

Patients will be randomly divided to four groups; group1 is anodal stimulation on the lesioned primary motor cortex, group 2 is cathodal stimulation on the non-lesioned primary motor cortex, group 3 is dual stimulation such as anodal stimulation on the lesioned side and cathod stimulation on the non-lesioned side, and group 4 is shame stimulation group.

The stimulation will be conducted 2mA for 20 minute a day, 5 days per weeks, totally 2 weeks.

Fugl-Meyer upper motor score will be measured as a primary outcome.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
72
Inclusion Criteria
  1. Age 20-85
  2. Unilateral Stroke patients
  3. Inclusion must be in the sub-acute phase defined as within 48hr-4 weeks after stroke
  4. Patients who have evoked motor potentials on the first dorsal interossei muscles on hemiplegic hand
  5. The patient has subscribed the informed consent
Exclusion Criteria
  1. Insert a metal object on the head
  2. Convulsive disorders
  3. History of brain diseases other than stroke

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Primary Outcome Measures
NameTimeMethod
Fugl-Meyer Upper Motor Score changebefore treatment, 48 hours after treatment, 4 weeks after treatment
Secondary Outcome Measures
NameTimeMethod
Range of Motion (ROM) changebefore treatment, 48 hours after treatment, 4 weeks after treatment
Korean version Modified Bathel Index (KMBI) changebefore treatment, 48 hours after treatment, 4 weeks after treatment
Manual Muscle Test (MMT) changebefore treatment, 48 hours after treatment, 4 weeks after treatment

Trial Locations

Locations (1)

Kim Yeon Hee

🇰🇷

Seoul City, Ilwon, Korea, Republic of

Kim Yeon Hee
🇰🇷Seoul City, Ilwon, Korea, Republic of
AH HE LEE, MS
Contact
82-2-6007-5408
ahee.lee@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.